124
Views
1
CrossRef citations to date
0
Altmetric
Open Peer Commentaries

“There Is No Man Living Who Isn’t Capable of Doing More Than He Thinks He Can Do” … With Cognitive Enhancement

Pages 54-56 | Received 16 Jan 2019, Accepted 25 Feb 2019, Published online: 09 May 2019

REFERENCES

  • Arria, A. M., I. M. Geisner, M. D. Cimini, J. R. Kilmer, K. M. Caldeira, A. L. Barrall, et al. 2018. Perceived academic benefit is associated with nonmedical prescription stimulant use among college students. Addictive Behaviors 76: 27–33. doi: 10.1016/j.addbeh.2017.07.013.
  • Bevan, S., I. Brinkley I, C. Cooper, and Z. Bajorek. 2018. Productivity and the workplace. In 21st century workforces and workplaces: The challenges and opportunities for future work practices and labour markets, 5–18. London, UK: Bloomsbury Publishing.
  • Conrad, E. C., S. Humphries, and A. Chatterjee. 2019. Attitudes toward cognitive enhancement: the role of metaphor and context. AJOB Neuroscience XX(XX): XX–XX.
  • Davis, N. J. 2017. A taxonomy of harms inherent in cognitive enhancement. Frontiers in Human Neuroscience 11: 1–9.
  • Franke, A. G., C. Bagusat, P. Dietz, et al. 2013. Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Medicine 11(1): 102. doi: 10.1186/1741-7015-11-102.
  • Fronda, G., M. Balcon, and D. Crivelli. 2018. Neuroethical implications of neurocognitive enhancement in managerial professional contexts. Journal of Cognitive Enhancement 2(4): 356–363. doi: 10.1007/s41465-018-0100-5.
  • Jerant, A., J. J. Fenton, R. L. Kravitz, et al. 2018. Association of clinician denial of patient requests with patient satisfaction. JAMA Internal Medicine 178(1): 85–91. doi: 10.1001/jamainternmed.2017.6611.
  • Joseph, J. 2013. Resilience as embedded neoliberalism: a governmentality approach. Resilience. 1: 38–52. doi: 10.1080/21693293.2013.765741.
  • Knorr-Cetina, K. 2005. The rise of a culture of life. The biological sciences are encouraging the move away from the ideals of the enlightenment towards an idea of individual perfectibility and enhancement EMBO Rep 6(S1): S76–S80.
  • Lakoff, G., and M. Johnson. 2008. Metaphors we live by. Chicago, IL: University of Chicago press. p. 3.
  • Maher, B. 2008. Poll results: Look who's doping. Nature 452(7188): 674–675. doi: 10.1038/452674a.
  • Mohamed, A. D. 2014. Neuroethical issues in pharmacological cognitive enhancement. Wiley Interdisciplinary Reviews: Cognitive Science 5(5): 533–549. doi: 10.1002/wcs.1306.
  • Munro, B. A., L. L. Weyandt, M. E. Marraccini, and D. R. Oster. 2017. The relationship between nonmedical use of prescription stimulants, executive functioning and academic outcomes. Addictive Behaviors 65: 250–257. doi: 10.1016/j.addbeh.2016.08.023.
  • Patton, D. 2018. Navigating drugs at university: Normalisation, differentiation and drift? Safer Communities 17(4): 224–237. doi: 10.1108/SC-01-2018-0002.
  • Pavarini, G., A. McKeown, and I. Singh. 2018. Smarter than thou, holier than thou: The dynamic interplay between cognitive and moral enhancement. Frontiers in Pharmacology 9: 1189–1200. doi: 10.3389/fphar.2018.01189.
  • Pennay, A. E., and F. C. Measham. 2016. The normalisation thesis – 20 years later. Drugs: Education, Prevention and Policy 23(3): 187–189. doi: 10.3109/09687637.2016.1173649.
  • Ross, M. M., A. M. Arria, J. P. Brown, et al. 2018. College students' perceived benefit-to-risk tradeoffs for nonmedical use of prescription stimulants: Implications for intervention designs. Addictive Behaviors 79: 45–51. doi: 10.1016/j.addbeh.2017.12.002.
  • Smith, C., and K. Riach. 2016. Drug taking and employment: Exploring the employable citizen in UK policy. Sociology 50(1): 24–42. doi: 10.1177/0038038514554330.
  • Sugden, C., R. Aggarwal, C. Housden, B. J. Sahakian, and A. Darzi. 2010. Pharmacological enhancement of performance in doctors. BMJ: British Medical Journal (Online) 340(may18 1): c2542. doi: 10.1136/bmj.c2542.
  • Zaltman, G., and R. H. Coulter. 1995. Seeing the voice of the customer: Metaphor-based advertising research. Journal of Advertising Research 35(4): 35–51. doi: 10.1080/00913367.2001.10673648.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.